Lilly’s Humalog Authorized Generic Will Not Quash Price Pressure

Eli Lilly has announced plans to introduce a generic version of its Humalog insulin lispro in the US at a 50% discount to the brand’s list price. However, political pressure is continuing to mount over the lack of availability of cheaper alternatives.

ClampCoins
Political Pressure On Insulin Pricing Continues Despite Lilly’s Launch • Source: Shutterstock

Eli Lilly will launch an authorized generic version of its Humalog (insulin lispro) 100U/ml in the US at a 50% discount to the brand’s list price, the firm has announced.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Products

More from Generics Bulletin